This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
However, the next few years are about to see major new legislation in the EU that could result in major disruption to Life Sciences, Pharmaceutical and Healthcare companies – wherever they are. The Life Sciences sector is used to constant regulatory change.
How does an emerging pharmaceutical company manage rapid growth, protect its intellectual property (IP) and comply with strict regulatory requirements? Ascentage Pharma turned to OpenText™ Documentum for Life Sciences™. Ascentage Pharma is a clinical-stage biopharmaceutical company that aims to improve the lives of patients.
If you work in the Life Sciences industry, your head will be nodding in confirmation while reading Forrester’s The Five Big Trends report, especially the part that states employee productivity has emerged as the second biggest driver for ECM investment in 2019. for OpenText Life Sciences Express appeared first on OpenText Blogs.
Every pharmaceutical company wants to accelerate the drug development process – from discovery to commercial success – to deliver new treatments that improve patient outcomes. At OpenText™, the Life Sciences team is committed to delivering better intelligent content services that drive productivity, growth and a lasting competitive advantage.
OpenText™ is thrilled to announce the launch of OpenText Content Cloud™ for Life Sciences, an innovative new offering that brings the proven productivity and governance capabilities of OpenText™ Documentum™ for Life Sciences to a cloud environment.
For the past three years, OpenText™ Enterprise World in July has been the destination of choice for business leaders and partners who have invested in Enterprise Information Management with OpenText.
Simplicity. That’s what every Life Sciences professional working with regulated business processes needs today. That’s exactly what they’re getting with the intuitive user experience and efficient cloud-based access of our new OpenText™ Life Sciences Express. Here’s why simplicity is so important.
When major acquisitions happen, market analysts, competitors, customers, and employees alike are watching closely to determine what’s next. In fact, employees like me were not terribly nervous when OpenText™ – a long-standing leader in enterprise content management – acquired Dell EMC’s Enterprise Content Division in January 2017.
Phil Beckman has extensive experience in the software industry including over a decade as the Director of Development for OpenText’s flagship ECM product (Livelink). He has worked closely with companies in both Pharmaceutical and Financial Services industries.
We organize all of the trending information in your field so you don't have to. Join 55,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content